» Articles » PMID: 29776237

Personalizing Rare Disease Research: How Genomics is Revolutionizing the Diagnosis and Treatment of Rare Disease

Overview
Journal Per Med
Date 2018 May 20
PMID 29776237
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A decade after the complete sequencing of the human genome, combined with recent advances in throughput and sequencing costs, the genetics of rare diseases has entered a new era. There has now been an explosion in the identification and mapping of rare diseases, with over 10,000 exomes having been sequenced to date. This article surveys the progress and development of technologies to understand rare disease; it provides a historical overview of traditional techniques such as karyotyping and homozygosity mapping, reviews current methods of whole-exome and -genome sequencing, and provides a future perspective on upcoming developments such as targeted drugs and gene therapy. This article will discuss the implications of these methods for rare disease research, along with a discussion of the success stories that provide great hope and optimism for patients and scientists alike.

Citing Articles

Queensland Consumers' Awareness and Understanding of Clinical Genetics Services.

Wallingford C, Cutler K, Istiko S, Fowles L, Lamb R, Bean J Front Genet. 2020; 11:537743.

PMID: 33193608 PMC: 7593610. DOI: 10.3389/fgene.2020.537743.


The combination of whole-exome sequencing and clinical analysis allows better diagnosis of rare syndromic retinal dystrophies.

Abu Diab A, AlTalbishi A, Rosin B, Kanaan M, Kamal L, Swaroop A Acta Ophthalmol. 2019; 97(6):e877-e886.

PMID: 30925032 PMC: 11377105. DOI: 10.1111/aos.14095.


Pharmacogenomics, Theranostics and Personalized Medicine - the complexities of clinical trials: challenges in the developing world.

Limaye N Appl Transl Genom. 2016; 2:17-21.

PMID: 27942441 PMC: 5133334. DOI: 10.1016/j.atg.2013.05.002.